Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Molina

Showing results (581-590 of 647) with videos related to

Pageof 65
Sort By:
Anticancer Research|May 1, 2001
Serum levels of CA 125 and TPS during treatment of ovarian cancerA Van Dalen, J Favier, L Baumgartner, et al.
BJU International|September 16, 2010
Complications and conversions of upper tract urological laparoendoscopic single-site surgery (LESS): multicentre experience: results from the NOTES Working GroupBrian H Irwin, Jeffrey A Cadeddu, Chad R Tracy, et al.
Cell Death and Differentiation|October 24, 2015
DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53S K Alam, V K Yadav, S Bajaj, et al.
ACS Biomaterials Science & Engineering|January 9, 2021
Effects of Shear Stress Gradients on Ewing Sarcoma Cells Using 3D Printed Scaffolds and Flow PerfusionJordan E Trachtenberg, Marco Santoro, Cortes Williams, et al.
European Journal of Gynaecological Oncology|January 27, 2010
Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-upA van Dalen, J Favier, E Hallensleben, et al.
Nutrients|November 27, 2024
Movement Behaviors and Bone Biomarkers in Young Pediatric Cancer Survivors: A Cross-Sectional Analysis of the iBoneFIT ProjectJose J Gil-Cosano, Esther Ubago-Guisado, Francisco J Llorente-Cantarero, et al.
Gynecologic Oncology|December 6, 2000
Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patientsA van Dalen, J Favier, A Burges, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2014
A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321Yujie Zhao, Nathan R Foster, Jeffrey P Meyers, et al.
ACS Biomaterials Science & Engineering|January 19, 2021
3D Tissue-Engineered Tumor Model for Ewing's Sarcoma That Incorporates Bone-like ECM and MineralizationEric R Molina, Letitia K Chim, Maria C Salazar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2011
Phase 1 study of the safety, tolerability, and pharmacokinetics of TH-302, a hypoxia-activated prodrug, in patients with advanced solid malignanciesGlen J Weiss, Jeffrey R Infante, E Gabriela Chiorean, et al.
Pageof 65

Showing results (581-590 of 647) with videos related to

Sort By:
Pageof 65
Anticancer Research|May 1, 2001
Serum levels of CA 125 and TPS during treatment of ovarian cancerA Van Dalen, J Favier, L Baumgartner, et al.
BJU International|September 16, 2010
Complications and conversions of upper tract urological laparoendoscopic single-site surgery (LESS): multicentre experience: results from the NOTES Working GroupBrian H Irwin, Jeffrey A Cadeddu, Chad R Tracy, et al.
Cell Death and Differentiation|October 24, 2015
DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53S K Alam, V K Yadav, S Bajaj, et al.
ACS Biomaterials Science & Engineering|January 9, 2021
Effects of Shear Stress Gradients on Ewing Sarcoma Cells Using 3D Printed Scaffolds and Flow PerfusionJordan E Trachtenberg, Marco Santoro, Cortes Williams, et al.
European Journal of Gynaecological Oncology|January 27, 2010
Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-upA van Dalen, J Favier, E Hallensleben, et al.
Nutrients|November 27, 2024
Movement Behaviors and Bone Biomarkers in Young Pediatric Cancer Survivors: A Cross-Sectional Analysis of the iBoneFIT ProjectJose J Gil-Cosano, Esther Ubago-Guisado, Francisco J Llorente-Cantarero, et al.
Gynecologic Oncology|December 6, 2000
Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patientsA van Dalen, J Favier, A Burges, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2014
A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321Yujie Zhao, Nathan R Foster, Jeffrey P Meyers, et al.
ACS Biomaterials Science & Engineering|January 19, 2021
3D Tissue-Engineered Tumor Model for Ewing's Sarcoma That Incorporates Bone-like ECM and MineralizationEric R Molina, Letitia K Chim, Maria C Salazar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2011
Phase 1 study of the safety, tolerability, and pharmacokinetics of TH-302, a hypoxia-activated prodrug, in patients with advanced solid malignanciesGlen J Weiss, Jeffrey R Infante, E Gabriela Chiorean, et al.
Pageof 65